Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Deloitte
US Army
Julphar
Teva
Queensland Health
Johnson and Johnson
Boehringer Ingelheim
Moodys

Generated: April 25, 2018

DrugPatentWatch Database Preview

NILUTAMIDE Drug Profile

« Back to Dashboard

When do Nilutamide patents expire, and when can generic versions of Nilutamide launch?

Nilutamide is a drug marketed by Ani Pharms Inc and is included in one NDA.

The generic ingredient in NILUTAMIDE is nilutamide. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the nilutamide profile page.
Drug patent expirations by year for NILUTAMIDE
Pharmacology for NILUTAMIDE
Synonyms for NILUTAMIDE
1-(3-'trifluoromethyl-4'-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione
1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl imidazolidine-2,5-dione
1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl-imidazolidine-2,5-dione
1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl-imidazoline-2,5-dione
1-(3-trifluoromethyl-4-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione
1-(3'-trifluoromethyl-4'-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione
1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazolidine-2,5-dione
1-(3'-trifluoromethyl-4'-nitrophenyl)4,4-dimethyl-imidazoline-2,5-dione
1-(3'-trifluoromethyl-4'nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione
1-(3'trifluoromethyl-4'-nitropheyl)-4,4-dimethyl-imidazoline-2,5-dione
2,4-IMIDAZOLIDINEDIONE, 5,5-DIMETHYL-3-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)-
3-(3-(trifluoromethyl)-4-nitrophenyl)-5,5-dimethylimidazolidine-2,4-dione
4CA-0906
5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)- 2,4-imidazolidinedione
5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)-2,4-imidazolidinedione
5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione
5,5-Dimethyl-3-(4-nitro-3-trifluoromethyl-phenyl)-imidazolidine-2,4-dione
5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin
5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-1,3-diazolidine-2,4-dione
5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione
5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-imidazolidine-2,4-dione
5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione
51G6I8B902
612N500
63612-50-0
A834440
AB00053180
AB00053180_07
AB0013969
AC-5260
AC1L1IAG
AJ-46401
AK-82300
AKOS005565152
AKOS025147305
AN-11150
Anandron
Anandron (TN)
ANW-58327
API0003576
AS-14123
Aventis Behring Brand of Nilutamide
Aventis Brand of Nilutamide
AX8041902
BCP9000990
BCPP000148
BDBM50135912
BIDD:GT0683
BIDD:PXR0177
Bio-0070
BPBio1_000920
BRD-K23566484-001-05-2
BRN 0841906
BSPBio_000836
BSPBio_003325
C-19507
C08164
C12H10F3N3O4
CAS-63612-50-0
CC-32857
CCG-39427
CHEBI:7573
CHEMBL1274
CTK8B7740
D00965
D0SN9T
DB00665
DivK1c_006998
DR001375
DSSTox_CID_14165
DSSTox_GSID_34165
DSSTox_RID_79118
DTXSID3034165
EU-0100879
FT-0080574
FT-0630740
GTPL2864
HE370407
HMS1570J18
HMS1922F03
HMS2093A10
HMS2097J18
HMS2230E03
HMS3262P19
HMS3268C18
HMS3369I02
Hoechst Brand of Nilutamide
I14-2740
K002
KB-58335
KBio1_001942
KBio2_002105
KBio2_004673
KBio2_007241
KBio3_002545
KBioGR_001100
KBioSS_002105
L000759
Lopac-N-8534
Lopac0_000879
LP00879
LS-79181
MCULE-3215206804
MFCD00864670
MLS002154066
MolPort-003-666-533
MolPort-005-975-300
N 8534
NCGC00015754-01
NCGC00015754-02
NCGC00015754-03
NCGC00015754-04
NCGC00015754-05
NCGC00015754-06
NCGC00015754-07
NCGC00015754-08
NCGC00015754-09
NCGC00015754-10
NCGC00015754-11
NCGC00015754-12
NCGC00015754-15
NCGC00015754-16
NCGC00025280-01
NCGC00025280-02
NCGC00025280-03
NCGC00025280-04
NCGC00025280-05
NCGC00025280-06
NCGC00025280-07
NCGC00025280-08
NCGC00255271-01
NCGC00261564-01
Nilandron
Nilandron (TN)
Nilandrone
Nilutamida
Nilutamida [Spanish]
Nilutamide (USAN/INN)
Nilutamide [USAN:BAN:INN]
Nilutamide [USAN:INN:BAN]
Nilutamide, European Pharmacopoeia (EP) Reference Standard
Nilutamide, solid
Nilutamidum
Nilutamidum [Latin]
NSC-758683
NSC758683
Pharmakon1600-01504152
Prestwick0_000928
Prestwick1_000928
Prestwick2_000928
Prestwick3_000928
PubChem19359
RU 23908
RU 23908-10
RU-23908
SBB067297
SBI-0050854.P003
SC-74493
SCHEMBL12670
SMR001233381
SPBio_002125
SPBio_003015
SpecPlus_000902
Spectrum_001625
SPECTRUM1504152
Spectrum2_001973
Spectrum3_001633
Spectrum4_000600
Spectrum5_001512
SR-01000076034
SR-01000076034-5
ST075550
STK633161
TC-030602
Tocris-1759
Tox21 110213
Tox21_110213
Tox21_110213_1
Tox21_301589
Tox21_500879
UNII-51G6I8B902
XWXYUMMDTVBTOU-UHFFFAOYSA-N
Z2417927201
ZINC3874498

US Patents and Regulatory Information for NILUTAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc NILUTAMIDE nilutamide TABLET;ORAL 207631-001 Jul 15, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Harvard Business School
Boehringer Ingelheim
Mallinckrodt
Fuji
AstraZeneca
Daiichi Sankyo
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.